Michael D Kishbauch's Net Worth

$7.95 Million

Estimate Recalculated Jun 6, 2024 03:13PM EST

Who is Michael D Kishbauch?

Michael D Kishbauch has an estimated net worth of $7.95 Million. This is based on reported shares across multiple companies, which include TETRALOGIC PHARMACEUTICALS Corp, Astria Therapeutics, Inc., PROGENICS PHARMACEUTICALS INC, ARIAD PHARMACEUTICALS INC, and ACHILLION PHARMACEUTICALS INC.

SEC CIK

Michael D Kishbauch's CIK is 0001076979

Past Insider Trading and Trends

2014 was Michael D Kishbauch's most active year for acquiring shares with 8 total transactions. Michael D Kishbauch's most active month to acquire stocks was the month of May. 2014 was Michael D Kishbauch's most active year for disposing of shares, totalling 10 transactions. Michael D Kishbauch's most active month to dispose stocks was the month of December. 2014 saw Michael D Kishbauch paying a total of $2,983,029.03 for 932,749 shares, this is the most they've acquired in one year. In 2014 Michael D Kishbauch cashed out on 1,735,498 shares for a total of $7,544,640.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

TETRALOGIC PHARMACEUTICALS Corp No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 28
Form 4
—
0
—
—
0
Nov 5
Form 3
—
0
—
—
0
No matching records found

Astria Therapeutics, Inc. (ATXS) Snapshot price: $14.67

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 5
Form 4
—
0
—
—
0
Jun 2
Form 4/A
—
0
—
—
0
Jun 9
Form 4
—
0
—
—
0
Jun 9
Form 4
—
0
—
—
0
Jun 2
Form 4
—
0
—
—
0
Jun 11
Form 4
—
0
—
—
0
Jun 4
Form 4
—
0
—
—
0
Jun 7
Form 4
—
0
—
—
0
Jul 27
Form 4
—
0
—
—
0
Apr 5
Form 3
—
0
—
—
0
No matching records found

PROGENICS PHARMACEUTICALS INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jul 11
Form 4
—
0
—
—
0
Jun 13
Form 4
—
0
—
—
0
Jun 14
Form 4
—
0
—
—
0
Jun 8
Form 4
—
0
—
—
0
Jun 10
Form 4
—
0
—
—
0
Mar 2
Form 4
—
0
—
—
0
Jun 17
Form 4
—
0
—
—
0
Sep 11
Form 3
—
0
—
—
0
No matching records found

ARIAD PHARMACEUTICALS INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+50.00%
10K
—
—
30K
Jan 18
Form 4
+100.00%
10K
—
—
20K
Jan 17 - Jan 18
Form 4
—
0
—
—
0
Jun 14
Form 4
—
0
—
—
0
Jan 17
Form 4
∞
10K
—
—
10K
Jan 17
Form 4
—
0
—
—
0
Dec 8
Form 3
—
0
—
—
0
No matching records found

ACHILLION PHARMACEUTICALS INC No price found

CEO and President

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 28
Form 4
—
0
—
—
0
Jan 23
Form 4
—
0
—
—
0
Feb 9
Form 4
—
0
—
—
0
Jan 19
Form 4
—
0
—
—
0
Jan 25
Form 4
—
0
—
—
0
Dec 2
Form 4
—
0
$6.46
-$2,921,503.92
0
Aug 15
Form 4
—
0
$5.43
-$1,729,507.05
0
Jun 10
Form 4
—
0
—
—
0
Dec 17
Form 4
—
0
—
—
0
Oct 8
Form 4
—
0
—
—
0
Dec 18
Form 4
—
0
$7.83
-$1,907,216.45
0
Jan 13
Form 4
—
0
$5.92
-$856,128.40
0
Jan 10 - Jan 11
Form 4
—
0
—
—
0
Dec 12
Form 4
—
0
$4.59
-$434,523.53
0
Jun 28
Form 4
—
0
$4.56
-$103,353.25
0
Jun 22 - Jun 24
Form 4
—
0
—
—
0
Dec 16
Form 4
—
0
—
—
0
Dec 18
Form 4
—
0
—
—
0
Dec 15
Form 4
—
0
—
—
0
Dec 14
Form 4
—
0
—
—
0
Dec 19
Form 3
—
0
—
—
0
No matching records found